Objective-Adiponectin and resistin are adipokines that are linked to obesity, inflammation, and atherosclerosis.
A therosclerosis is a chronic inflammatory process resulting from the interaction of modified lipoproteins, monocyte-derived macrophages, T cells, and the normal cellular elements of the arterial wall. 1 Atherosclerotic plaques contain many inflammatory cells, such as macrophages, which secrete several cytokines that cause weakening of the fibrous plaque cap. 2, 3 The rupture of an atherosclerotic plaque and the subsequent formation of the thrombi are the main factors responsible for myocardial infarction and cerebral infarctions. The biological compositions and inflammatory state of an atherosclerotic plaque, rather than the degree of stenosis or its size, are the major determinants of acute clinical events. 4 Adiponectin is a metabolically active adipokine that is inversely associated with obesity, insulin resistance, and atherosclerosis. 5, 6 Previous studies have indicated that adiponectin has antiinflammatory, antiatherogenic, and antidiabetic properties. 7 Adiponectin is independently associated with a reduced risk of type 2 diabetes 8 and a decreased coronary heart disease risk in diabetic men. 9 Moreover, high plasma adiponectin levels were associated with a lower risk of myocardial infarction in men during the 6 years of follow-up in the Health Professionals Follow-Up Study. 10 On the other hand, resistin was originally discovered as an adipokine that was suggested to be a link between obesity and insulin resistance in rodents. 11 In contrast to rodents, human resistin is expressed primarily in inflammatory cells and has been shown to be involved in obesity-related subclinical inflammation, atherosclerosis, and cardiovascular disease (CVD). 12 Reilly et al 13 showed that circulating resistin levels are correlated with inflammation markers and are predictive of coronary atherosclerosis measured using coronary artery calcification scores, independent of C-reactive protein.
Recently, positron emission tomography (PET) with 18 Ffluorodeoxyglucose (FDG) has emerged as a novel imaging technique to identify vascular inflammation. 14 FDG accumulates in plaque macrophages, and its uptake is correlated with macrophage density. Tawakol et al 15 reported a significant correlation between the PET signal from carotid plaques and macrophage staining from the corresponding histological sections (rϭ0.70; PϽ0.001). Rudd et al 16 demonstrated that atherosclerotic plaque inflammation can be imaged with FDG-PET and that symptomatic, unstable plaques accumulate more FDG than do asymptomatic lesions. Recently, we found that FDG uptake values measured using FDG-PET/ computed tomography (CT) were significantly increased in patients with impaired glucose tolerance or type 2 diabetes compared with the normal subjects and correlated with cardiovascular risk factors. 17 Therefore, FDG-PET has been recognized as one of the advanced imaging approaches that can be used to evaluate vascular inflammation. 18 In this study, we examined the associations among circulating adiponectin, resistin levels, and vascular inflammation using FDG-PET/CT in healthy volunteers without known CVD or diabetes. In addition, we compared carotid intimamedia thickness (CIMT) and target-to-background ratio (TBR) measured using FDG-PET/CT in obese and nonobese groups.
Materials and Methods

Study Design and Participants
We prospectively enrolled 120 apparently healthy participants who underwent a medical checkup in the health promotion center in Korea University Guro Hospital using predefined inclusion and exclusion criteria. Participants included 60 obese subjects (body mass index [BMI] Ն25 kg/m 2 ) and 60 nonobese controls (BMI Ͻ25 kg/m 2 ). No participants had history of CVD (myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization), diabetes, stage 2 hypertension (resting blood pressure Ն160/100 mm Hg), malignancy, or severe renal or hepatic disease. Participants were free of any lipid-lowering therapies and postmenopausal hormone replacement therapy for at least the 6-month period before enrollment. We also excluded subjects with a history of inflammatory condition or those taking medications that might affect the inflammatory status within the previous 6 months. All participants provided written informed consent, and the Korea University Institutional Review Board, in accordance with the Declaration of Helsinki of the World Medical Association, approved this study protocol.
Anthropometric and Laboratory Measurements
BMI was calculated as weight/height 2 (kg/m 2 ), and waist circumference was measured at the midpoint between the lower border of the rib cage and iliac crest. All blood samples were obtained in the morning after a 12-hour overnight fast and were immediately stored at Ϫ80°C for subsequent assays. Serum triglycerides and highdensity lipoprotein (HDL) cholesterol levels were determined enzymatically using a chemistry analyzer (Hitachi 747, Hitachi, Tokyo, Japan), and the low-density lipoprotein (LDL) cholesterol concentration was estimated using the Friedewald formula. 19 A glucose oxidase method was used to measure plasma glucose, insulin resistance (IR) was calculated using the homeostasis model assessment (HOMA), 20 and high-sensitivity C-reactive protein (hsCRP) levels were determined via a chemiluminescence immunoassay (Beckman Coulter, Brea, CA). Serum adiponectin levels were measured using ELISA (Mesdia, Seoul, Korea), and the intraassay and interassay variations were 5.0%, respectively. Serum resistin levels were measured using ELISA (AdipoGen, Incheon, Korea), and the interassay and intraassay variations were 3.7% and 5.6%, respectively.
Measurement of CIMT
The intima-media thickness (IMT) of the common carotid artery was determined using high-resolution B-mode ultrasonography (EnVisor, Philips Medical Systems, Andover, MA) with a 5-to 12-MHz transducer. Measurements of CIMT were made using the IMT measurement software Intimascope (Media Cross Co, Tokyo, Japan) at 3 levels of the lateral and medial walls, 1 to 3 cm proximal to the carotid bifurcation. The mean IMT was the average value of 99 computer-based points in the region, and the maximal IMT was the IMT value at a maximal point of the region. All measurements were recorded by a single trained technician who was blinded to the subject's anthropometric and laboratory data.
F-FDG PET/CT Imaging
PET/CT was performed using the Gemini TF 16-Slice PET/CT scanner (Philips Medical Systems). The TF scanner is a new high-performance, time-of-flight-capable, fully 3-dimensional PET scanner using lutetium-yttrium oxyorthosilicate crystals. After at least 12 hours of fasting, 18 F-FDG (370 to 550 MBq) was injected intravenously, and then the patients rested in a quiet room for 60 minutes. A whole body PET image (below cerebellum to inguinal) was acquired for 10 minutes (1 minute per bed), and PET image analysis was performed on a dedicated workstation (Extended Brilliance Workspace 3.5 with PET/CT viewer for automated image registration, Philips). Right carotid FDG uptake was measured along the length of the right carotid vessel, starting at the bifurcation and extending inferiorly and superiorly every 4 mm. Arterial FDG uptake was quantified in a region of interest around each artery on every slice of the coregistered transaxial PET/CT images. The region of interest was fitted to the artery wall on each axial slice, and coronal and sagittal views were used to ensure that the FDG uptake occurred in the artery. The standardized uptake value (SUV) was the decaycorrected tissue concentration of FDG (in kBq/mL) divided by the injected dose per body weight (kBq/g). The arterial SUV value was normalized to the blood pool SUV value measured from the jugular vein (standardized circular regions of interest; right carotid artery, areaϭ77.9Ϯ3.42 mm 2 , 9 pixels; right jugular vein, areaϭ95.0Ϯ12.7 mm 2 , 9 pixels). Afterward, a TBR was calculated as the right carotid vessel plaque SUV divided by the venous blood SUV, and a mean and maximum value of TBR was calculated for each patient. To determine the variabilities in the mean and maximum TBR measurements, images from 20 subjects were twice analyzed, several weeks apart, by 2 readers blinded to the subject's clinical history. The intraand interobserver correlation coefficient values of the mean and maximum TBR measurements were Ͼ0.8.
Statistical Analysis
Data are expressed as meanϮSD or median (interquartile range). Differences between groups were tested using the independent 2-sample t test, Mann-Whitney U test, or 2 test. Spearman rank correlation tests were performed to determine the relationships between TBR, hsCRP, CIMT values, and other cardiovascular risk variables. To test adipokine trends according to serum mean TBR level tertiles, 1-way ANOVA and the Kruskal-Wallis test were performed. Multiple regression analysis was conducted using the mean TBR as a dependent variable. Age, gender, BMI, waist circumference, smoking, systolic blood pressure, diastolic blood pressure, HDL cholesterol, LDL cholesterol, triglyceride, serum fasting glucose level, HOMA-IR, serum adiponectin level, serum resistin level, and hsCRP level were adopted as independent variables. Data were analyzed using SPSS for Windows (version 12.0, SPSS Inc., Chicago, IL), and a probability value Ͻ0.05 indicated statistical significance.
Results
Patient Characteristics
Clinical and biochemical characteristics of the study subjects are shown in Figure 1A ). However, there were no significant differences in mean IMT or resistin levels between the obese and nonobese groups (Table 1, Figure 1B ).
Imaging and Clinical Parameters
In a Spearman correlation analysis, adiponectin levels were negatively correlated with BMI, waist circumference, total cholesterol, LDL cholesterol, triglyceride, fasting plasma glucose, HOMA-IR, and hsCRP levels and positively correlated with HDL cholesterol level and age (all PϽ0.05). Importantly, adiponectin levels showed a negative relationship with mean TBR values (rϭϪ0.215, Pϭ0.020), whereas resistin levels showed a positive relationship with mean TBR values (rϭ0.214, Pϭ0.021) (Figure 2) . Resistin levels showed a positive relationship with IMT values, whereas adiponectin levels had no significant correlation with IMT values. In the present study, there was a significant positive relationship between mean TBR and CIMT values (rϭ0.207, Pϭ0.024). Table 2 shows the clinical and laboratory variables stratified by tertiles of mean TBR levels. Significant differences in BMI, waist circumference, fasting glucose, total cholesterol, LDL cholesterol, hsCRP, maximal IMT, adiponectin, and resistin levels between groups were noted (all PϽ0.05).
Univariate analysis showed that mean TBR values were significantly associated with gender, BMI, waist circumference, fasting glucose, HOMA-IR, LDL cholesterol, triglyceride, hsCRP, adiponectin, and resistin levels (Table 3) . When multiple stepwise regression analysis was performed using mean TBR as a dependent variable, hsCRP (Pϭ0.01), BMI (Pϭ0.014), and resistin levels (Pϭ0.046) were independently associated with mean TBR values (R 2 ϭ0.308) ( Table 3) .
Discussion
Using FDG-PET/CT, we found that patients in the obese group had increased TBR values, reflecting vascular inflammation, compared with those of the nonobese group. Furthermore, vascular inflammation was positively correlated with resistin and negatively correlated with adiponectin. In particular, resistin showed an independent association with vascular inflammation, even after consideration of other risk factors associated with atherosclerosis.
Resistin is derived almost exclusively from adipose tissue in rodents, 11 but it is expressed primarily in inflammatory cells, especially macrophages, in humans. 21 In the rodent model, resistin was initially suggested to be a link between obesity and insulin resistance, 11,22 but this has not been shown in humans. Instead, resistin expression was found to be abundant in monocytes/macrophages, which play an important role in inflammation and atherosclerosis. 21, 23, 24 Kawanami et al 25 (SR-A and CD36) and ATP-binding cassette transporter-A1 in macrophages. In a population-based cross-sectional study of 3193 Chinese subjects, resistin was more strongly associated with inflammatory and fibrinolytic markers than with obesity or insulin resistance status. 27 In men with acute myocardial infarction, a multivariate model revealed that obesity and C-reactive protein were independent variables associated with higher resistin levels. 28 Moreover, Weikert et al 29 reported that among 26 490 middle-aged subjects, individuals in the highest quartile of resistin level, compared with those in the lowest quartile of resistin level, had a significantly increased risk of myocardial infarction after adjustment for cardiovascular risk factors, including C-reactive protein (relative risk, 2.09; 95% confidence interval, 1.01 to 4.31). Recently, in 397 Korean patients with acute myocardial infarction, high resistin levels were predictors for all-cause mortality, independent of other risk factors. 30 These studies suggest that resistin may represent a novel link of metabolic signals, inflammation, and atherosclerosis. The present study demonstrates the association of resistin level and the TBR values that reflect vascular inflammation, even after adjusting for other cardiovascular risk factors, including hsCRP.
Adiponectin, a circulating adipose tissue-derived hormone, is downregulated in obese individuals. Experimental studies have shown that adiponectin plays a protective role in the development of insulin resistance, inflammation, and atherosclerosis. Hypoadiponectinemia has been established as an independent risk factor for type 2 diabetes and CVD. 31 The present study confirmed that circulating adiponectin levels were negatively correlated with cardiovascular risk profiles, such as BMI, waist circumference, lipid profiles, insulin resistance, and hsCRP levels. Although the role of adiponectin is attractive as a biomarker for estimating the risk of atherosclerotic CVD, several recent studies have reported conflicting results. Wannamethee et al 32 reported that high adiponectin levels were associated with increased all-cause and CVD mortality in older men with heart failure. Hajer et al 33 also reported that lower adiponectin levels were associated with a lower cardiovascular risk in patients with clinical evident vascular disease. There is no clear explanation for this discrepancy. In this study including middle-aged participants without known CVD, adiponectin levels were correlated negatively with vascular inflammation measured using FDG-PET/CT. However, this relationship was attenuated after adjusting for other cardiovascular risk factors, including hsCRP, a marker of systemic inflammation that predicts the risk of CVD.
There is growing evidence that vascular inflammation is involved in atherosclerosis. Epidemiological and experimental studies have established that intima-media thickness of the carotid and femoral arteries is a valid surrogate marker for the progression of atherosclerotic disease. 34 However, CIMT does not provide information about plaque composition or inflammatory state; FDG-PET may effectively detect the inflammatory state of an atherosclerotic plaque. Ogawa et al 35 reported that macrophages are responsible for the accumulation of FDG in atherosclerotic lesions, and FDG uptake is correlated with macrophage density. Silvera et al 36 evaluated the relationship between atherosclerotic plaque inflammation, as assessed by FDG-PET/CT, and plaque morphology and composition, as assessed by magnetic resonance imaging. They found that the TBR value was higher in the lipidnecrotic core group compared with collagen and calcium groups in 16 patients with cardiovascular risk factors. On the other hand, FDG-PET imaging of atherosclerotic plaque inflammation is highly reproducible, with favorable inter-and intraobserver agreement. 37 In addition, Tahara et al 38 showed that the age-and gender-adjusted SUV of FDG was significantly higher (PϽ0.0001) in proportion to the number of components of metabolic syndrome in 216 consecutive subjects for cancer screening. Furthermore, Rominger et al 39 recently reported that increased TBR value was an independent predictor for the occurrence of vascular events in 932 otherwise asymptomatic cancer patients. In our study, mean TBR values in the carotid artery had significant correlations with cardiovascular risk factors, such as BMI, waist circumference, fasting plasma glucose, insulin resistance, LDL cholesterol, triglyceride, and hsCRP. Furthermore, multiple regression analysis showed that TBR values were independently associated with circulating inflammatory markers, such as hsCRP and resistin, independently of BMI.
Conclusions
Serum adiponectin and resistin levels showed significant correlation with vascular inflammation, as represented by TBR values measured using FDG-PET/CT. These results suggest that adiponectin and resistin may be useful circulating biomarkers that reflect vascular inflammation. Additional prospective studies are needed to support the use of adiponectin, resistin levels, and FDG-PET imaging as predictors of risk for developing atherosclerosis and CVD. 
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